Gerard Rennick (Queensland, Liberal Party) Share this | Hansard source

I'm glad Senator Ayres has raised the issue of the ABS mortality figures because that is exactly what I was going to talk about today. I want to emphasise that I want to talk about all-cause mortality, not excess deaths, because excess deaths are a modelled figure; I want to talk about the actual figures.

In 2019, Australia had 164,000 deaths. In 2020, once COVID started and we had the lockdowns, Australia had 162,000 deaths. In 2021, Australia had 172,000 deaths. There was a rise in 2021 of 10,000 deaths in Australia, despite the fact that Australia did not have an increase in population that year. So the question is this: what caused the rise in deaths by10,000 people? And those deaths occurred in the last eight months of the year. So in the first four months of the year, before the COVID vaccine rollout, there was no increase in deaths from the prior year. That means that the jump in deaths was over a thousand people per month from May onwards. Those figures are recorded in the ABS figures. They are a fact. Now, the question has to be asked: why did all-cause mortality, the number of deaths, rise after the COVID vaccine was rolled out but before COVID was in the community, in December 2021?

When we look at the hospital admissions for myocarditis and heart conditions, they jumped as well. We have had the TGA admit that that was because the vaccine caused autoimmune issues. We know that from the TGA report. I don't have to read studies; I read the actual non-clinical report on the COVID vaccine and the product assessment report. This is an mRNA vaccine, a technology that I happened to invest very heavily in prior to coming into parliament. So I'm not some Luddite that is against the technology. I invested in a company called Viralytics which was designed to be used on patients who had stage 3 and stage 4 cancer. They eventually got taken over by Merck & Co. That's why I am familiar with the technology.

The thing about the mRNA vaccine is that this was the first time that a drug was ever designed to be delivered inside a human cell. This is the key distinction between an mRNA vaccine and a protein vaccine. Because it goes inside the cell via a process called transfection, which is a novel technology, it induces a T cell response. The body's immune system recognises the foreign body inside a cell and it attacks an otherwise healthy cell. This is a key difference between a protein vaccine, where the immune system recognises the foreign body and generates B cells to attack the foreign protein. The mRNA vaccine generates a T cell to destroy your cell.

What we also know is that the coronavirus has 29 proteins. Normally in a traditional protein vaccine you pull off the spike protein and you get 28 other proteins. It's quite a large macromolecule. That is too big to cross the endothelium of the bloodstream. You therefore don't get the same biodistribution as you do with an mRNA vaccine. Because of that, we know from the biodistribution studies on page 45 of the non-clinical report TGA FOI 2389-6, the lipids went throughout all organs in the animal studies. That means all organs are susceptible to autoimmune response by the actual human body. What's more concerning is the fact that the spleen and the bone marrow don't have ACE receptors. The virus cannot get into the white blood cells. The exception to that, of course, is AIDS, which attacks white blood cells. Most other viruses can't attack white blood cells. So by the vaccine—and we saw this on page 45—allowing the lipids to go into the spleen and the bone marrow you are inducing an autoimmune response in all your organs. We have seen an increase in diabetes. That is an autoimmune disease. That is more evidence, along with the increase in people being admitted to hospital with myocarditis, of autoimmune issues.

People are entitled to know. As Senator Ayres said, every life is important. People are entitled to know why 10,000 extra people died in the period before COVID was in the community yet after the vaccine rollout.